TRC105, a novel chimeric IgG1 anti-CD105/endoglin monoclonal antibody with high avidity, induces antibody-dependent cellular cytotoxicity and apoptosis in human umbilical vein endothelial cells and CD105+ tumor cells (Rosen et al., 2012). The gene discussed is ENG; the disease is neoplasm.